$120M
The financing round was co-led by RA Capital Management and Forbion to support late-stage clinical development.
C
CellCentric
CellCentric develops novel oral targeted therapies to treat resistant blood cancers.
United Kingdom—Founded 2003
$120MTotal raised
CellCentric is a clinical-stage biotechnology company developing oral targeted treatments for cancer, with a primary focus on multiple myeloma.
Categories
Team
AS
Azim Surani
Founder
WW
Will West
CEO